- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01043562
Precise Measurement of Pediatric Defibrillation Thresholds
July 24, 2017 updated by: Andrew Eric Radbill, Boston Children's Hospital
Defibrillation Thresholds in a Pediatric Cohort Using Binary Search Protocol
Patients who receive an implantable cardioverter-defibrillator (ICD) usually undergo testing at the end of the ICD procedure to measure the amount of energy able to successfully defibrillate the heart (defibrillation threshold testing, or DFT).
This study proposes to perform that measurement in pediatric patients already undergoing clinically necessary ICD procedures, with the measurement performed using a binary search method that has been previously validated in adult cohorts.
We hypothesize that pediatric DFTs, when precisely measured, may be lower than previously assumed from extrapolation of adult data.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Children's Hospital Boston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients seen by the electrophysiology service at Children's Hospital Boston who are identified to be at very high risk of sudden cardiac death and in need of an ICD
Description
Inclusion Criteria:
- Current follow-up at Children's Hospital Boston
- Children with current or planned ICDs who are scheduled by their primary electrophysiologist for clinically necessary assessment/re-assessment of defibrillation threshold
- If the patient has an ICD system with a non-transvenous shock coil: weight ≤35kg at time of initial implant, with current weight <50kg
- If the patient has an ICD system with a conventional transvenous shock coil: current weight ≤60kg
Exclusion Criteria:
- Clinical failure of any system component not able to be addressed by hardware repair or exchange
- Hemodynamic instability that in the judgment of the primary electrophysiologist warrants abbreviation of DFT assessment
- Unsuccessful induction of fibrillation during DFT testing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Pediatric ICD pts
Inclusion criteria for study participants included: 1) weight ≤60 kg, 2) new or existing ICD system, and 3) clinically necessary assessment of the defibrillation efficacy of the ICD system.
Transvenous systems utilized a high-voltage ICD coil with active-fixation lead attached to the right ventricular endocardial surface, whereas non-transvenous systems depended upon a high-voltage shocking coil placed within the pericardial, subcutaneous or pleural space.
To be included in the post-shock pacing portion of the study, adequate sinus and AV node function had to be present at baseline.
Exclusion criteria included 1) tenuous hemodynamic status felt to warrant abbreviation of the defibrillation efficacy testing or 2) inability to induce fibrillation during defibrillation threshold testing (DFT).
|
Measurement of the defibrillation threshold was performed using a modified binary search protocol.
This protocol specified three distinct inductions of ventricular fibrillation (VF) for all subjects, with a 3-5 minute observation/waiting period between inductions.
The initial shock energy was programmed at 9 joules (J) for all patients, with internal rescue shocks at 31J followed by device-specific maximum deliverable energy.
The outcome of the initial induction determined the programmed energies for both the initial and internal rescue shocks for the second induction, and likewise for the third induction.
All shocks were biphasic and delivered at manufacturers' default tilt, polarity and duration, and all final programmed shock vectors included an active can.
External defibrillation pads were in place for delivery of external rescue shock should the internal shocks fail.
Prior to each of the three ventricular fibrillation inductions performed as part of the binary search protocol, post-shock pacing was re-programmed using a pre-determined, stepwise protocol that progressively decreased the lower rate limit.
For the purpose of this protocol, post-shock pacing was considered necessary if 1) ≥7 ventricular-paced beats or 2) asystole >4 seconds was observed in the first 20 seconds after defibrillation, or if the systolic blood pressure demonstrated a >10% decrease from pre-induction baseline at follow-up measurement 1 minute post-defibrillation.
Rescue ventricular pacing via the programmer was available for all subjects.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Defibrillation Threshold
Time Frame: During clinical ICD procedure, as a single event
|
The defibrillation threshold is a measure of the minimum amount of energy (in Joules) that is able to successfully defibrillate an episode of ventricular fibrillation.
This measurement is specific to each individual patient with his/her specific defibrillator configuration.
There are several different strategies to measuring this in an individual patient; this study utilized the binary search protocol.
|
During clinical ICD procedure, as a single event
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Do DFTs Vary by Type of ICD Systems Implanted?
Time Frame: During clinical ICD procedure, as a single event
|
The defibrillation threshold (as measured in Joules as already described in the details regarding the primary outcome) will be compared between patients with two distinct general types of implanted defibrillator systems: 1) transvenous ICD systems (defibrillator leads located inside the vein and attached to the endocardial surface of the heart) and 2) non-transvenous ICD systems (including all other types of debrillation systems).
|
During clinical ICD procedure, as a single event
|
Intrinsic Heart Rate in the Immediate Post-defibrillation Period
Time Frame: During clinical ICD procedure, as a single event
|
A patient will be considered to have an intrinsic slow heart rate in the period of time immediately following defibrillation (20 seconds) if any of the following are observed: >7 paced beats, asystole >4 seconds, or experienced >10% decrease in systolic blood pressure.
|
During clinical ICD procedure, as a single event
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Andrew E Radbill, MD, Boston Children's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 4, 2009
Primary Completion (Actual)
May 26, 2010
Study Completion (Actual)
May 10, 2012
Study Registration Dates
First Submitted
January 6, 2010
First Submitted That Met QC Criteria
January 6, 2010
First Posted (Estimate)
January 7, 2010
Study Record Updates
Last Update Posted (Actual)
February 5, 2018
Last Update Submitted That Met QC Criteria
July 24, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 09-04-0209
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatrics
-
Vanderbilt UniversityRita & Alex Hillman FoundationCompleted
-
Fundación para el Fomento de la Investigación Sanitaria...CompletedPediatrics | EchocardiographySpain
-
Kasr El Aini HospitalCompleted
-
Johns Hopkins UniversityThe Thomas Wilson Sanitarium for Children of Baltimore CityTerminated
-
University of FloridaRecruitingTelemedicine | PediatricsHaiti
-
University of CalgaryCompletedHealthy | PediatricsCanada
-
University of CalgaryCompleted
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedPediatrics | Anesthesiology
-
Emergency Medical Services, Capital Region, DenmarkRigshospitalet, Denmark; University of Copenhagen; Copenhagen University Hospital... and other collaboratorsCompletedEfficacy, Self | Pediatrics | TriageDenmark
-
Tanta UniversityCompletedMRI | Dexmedetomidine | Pediatrics | MidazolamEgypt
Clinical Trials on Defibrillator threshold testing
-
CMC Ambroise ParéCompletedImplantable Cardioverter-DefibrillatorsFrance
-
William Beaumont HospitalsCompleted
-
The Cooper Health SystemUniversity of Washington; MedtronicUnknownVentricular ArrhythmiasUnited States
-
Massachusetts Eye and Ear InfirmaryBoston Children's Hospital; University of WashingtonRecruiting
-
Associates in Cardiology, PAMedtronicUnknownTachycardia, Ventricular | Heart Failure, CongestiveUnited States
-
University of GiessenRecruiting
-
University of NottinghamVersus Arthritis; Nottingham Biomedical Research Centre; Muculoskeletal Association...Completed
-
University Medical Centre LjubljanaRecruitingTaste Disorders | Chorda Tympani Disorder | Stapes FixationSlovenia
-
Baylor College of MedicineCompletedPediatric ResidentsUnited States
-
Abbott Medical DevicesUniversity of WashingtonCompletedVentricular Fibrillation | Ventricular Tachycardia | Congestive Heart Failure | Sudden Cardiac Death